Subthalamic nucleus deep brain stimulation on motor‐symptoms of Parkinson's disease: Focus on neurochemistry

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Progress in neurobiology

• Publication date

  2017-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.pneurobio.2017.01.003PMID 28159574
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Parkinson's disease].

  2022cited by this paper
• Subjective perceived outcome of subthalamic deep brain stimulation in Parkinson's disease one year after surgery.

  2016cited by this paper
• A decade of emerging indications: deep brain stimulation in the United States.

  2016cited by this paper
• Extrinsic Sources of Cholinergic Innervation of the Striatal Complex: A Whole-Brain Mapping Analysis

  2016cited by this paper
• Our first decade of experience in deep brain stimulation of the brainstem: elucidating the mechanism of action of stimulation of the ventrolateral pontine tegmentum

  2016cited by this paper
• Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson’s disease

  2016cited by this paper
• Distinct roles of cortical and pallidal β and γ frequencies in hemiparkinsonian and dyskinetic rats.

  2016cited by this paper
• Cortical Plasticity Induction by Pairing Subthalamic Nucleus Deep-Brain Stimulation and Primary Motor Cortical Transcranial Magnetic Stimulation in Parkinson's Disease

  2016cited by this paper
• Deep brain stimulation in early stage Parkinson's disease may reduce the relative risk of symptom worsening.

  2016cited by this paper
• The effect of dopaminergic therapy on intraoperative microelectrode recordings for subthalamic deep brain stimulation under GA: can we operate on patients ‘on medications’?

  2016cited by this paper
• Non-Human Primate: An Essential Building Brick in the Discovery of the Subthalamic Deep Brain Stimulation Therapy

  2016cited by this paper
• The combined depletion of monoamines alters the effectiveness of subthalamic deep brain stimulation.

  2015cited by this paper
• Reduced cortical innervation of the subthalamic nucleus in MPTP-treated parkinsonian monkeys.

  2015influential reference
• Deep brain stimulation may reduce the relative risk of clinically important worsening in early stage Parkinson's disease.

  2015cited by this paper
• Deep-brain stimulation associates with improved microvascular integrity in the subthalamic nucleus in Parkinson's disease.

  2015cited by this paper
• Effect of Subthalamic Deep Brain Stimulation on Levodopa-Induced Dyskinesia in Parkinson's Disease

  2015cited by this paper
• Interaction of noradrenergic pharmacological manipulation and subthalamic stimulation on movement initiation control in Parkinson's disease.

  2015cited by this paper
• The medical treatment of patients with Parkinson's disease receiving subthalamic neurostimulation.

  2015influential reference
• Commentary: Clinical Correlates of Raphe Serotonergic Dysfunction in Early Parkinson’s Disease

  2015influential reference
• A preoperative metabolic marker of parkinsonian apathy following subthalamic nucleus stimulation

  2015cited by this paper
• Suicide in Parkinson's Disease Patients Treated With Levodopa‐Carbidopa Intestinal Gel

  2015cited by this paper
• The timing of deep brain stimulation for Parkinson disease in the UK from 1997 to 2012

  2015cited by this paper
• Deep brain stimulation for movement disorders: 2015 and beyond.

  2015cited by this paper
• Psychogenic and neural visual-cue response in PD dopamine dysregulation syndrome.

  2015cited by this paper
• Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease.

  2015cited by this paper
• Electrical high frequency stimulation modulates GABAergic activity in the nucleus accumbens of freely moving rats.

  2015cited by this paper
• Are we close to the advent of closed loop deep brain stimulation in Parkinson's disease?

  2015cited by this paper
• Interneuronal Nitric Oxide Signaling Mediates Post-synaptic Long-Term Depression of Striatal Glutamatergic Synapses.

  2015cited by this paper
• Deep brain stimulation of the subthalamic nucleus: All that glitters isn't gold?

  2015influential reference
• Effects of subthalamic nucleus stimulation on motor cortex plasticity in Parkinson disease

  2015cited by this paper
• Disruption of dopaminergic transmission remodels tripartite synapse morphology and astrocytic calcium activity within substantia nigra pars reticulata

  2015influential reference
• Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease.

  2015cited by this paper
• Deep Brain Stimulation of the Rat Subthalamic Nucleus Induced Inhibition of Median Raphe Serotonergic and Dopaminergic Neurotransmission.

  2015cited by this paper
• Reply to letter: Suicide in Parkinson's disease patients treated with levodopa‐carbidopa Intestinal Gel

  2015cited by this paper
• Cerebellar and Motor Cortical Transcranial Stimulation Decrease Levodopa-Induced Dyskinesias in Parkinson’s Disease

  2015cited by this paper
• Cognition and Depression Following Deep Brain Stimulation of the Subthalamic Nucleus and Globus Pallidus Pars Internus in Parkinson’s Disease: A Meta-Analysis

  2015cited by this paper
• The 5‐HT4 Agonist Prucalopride Stimulates L‐DOPA‐Induced Dopamine Release in Restricted Brain Regions of the Hemiparkinsonian Rat In Vivo

  2015cited by this paper
• Suicide and dopamine agonist withdrawal syndrome in Parkinson's disease

  2015cited by this paper
• Postoperative apathy can neutralise benefits in quality of life after subthalamic stimulation for Parkinson's disease

  2015cited by this paper
• Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson’s Disease

  2015cited by this paper
• Subthalamic deep brain stimulation differently alters striatal dopaminergic receptor levels in rats

  2015cited by this paper
• Changes in GABA and glutamate concentrations during memory tasks in patients with Parkinson’s disease undergoing DBS surgery

  2014cited by this paper
• Pharmacogenetic and optical dissection for mechanistic understanding of Parkinson's disease: potential utilities revealed through behavioural assessment.

  2014cited by this paper
• Lack of depotentiation at basal ganglia output neurons in PD patients with levodopa-induced dyskinesia.

  2014influential reference
• High frequency stimulation of subthalamic nucleus results in behavioral recovery by increasing striatal dopamine release in 6-hydroxydopamine lesioned rat.

  2014cited by this paper
• Serotonin Impairment in CSF of PD Patients, without an Apparent Clinical Counterpart

  2014cited by this paper
• The impact of age and disease duration on the long term outcome of neurostimulation of the subthalamic nucleus.

  2014cited by this paper
• Dopamine and the Biology of Creativity: Lessons from Parkinson’s Disease

  2014cited by this paper
• Imagined gait modulates neuronal network dynamics in the human pedunculopontine nucleus

  2014cited by this paper
• Pregnenolone sulfate restores the glutamate-nitric-oxide-cGMP pathway and extracellular GABA in cerebellum and learning and motor coordination in hyperammonemic rats.

  2014cited by this paper
• Subthalamotomy in the treatment of Parkinson's disease: clinical aspects and mechanisms of action.

  2014cited by this paper
• Deep Brain Stimulation: Are Astrocytes a Key Driver Behind the Scene?

  2014cited by this paper
• Phosphodiesterase 10 inhibitors: new disease modifying drugs for Parkinson's disease?

  2014cited by this paper
• Pedunculopontine Nucleus Stimulation: Where are We Now and What Needs to be Done to Move the Field Forward?

  2014cited by this paper
• Unilateral deep brain stimulation of the pedunculopontine tegmental nucleus in idiopathic Parkinson's disease: effects on gait initiation and performance.

  2014cited by this paper
• L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum

  2014cited by this paper
• Increased Precursor Cell Proliferation after Deep Brain Stimulation for Parkinson's Disease: A Human Study

  2014cited by this paper
• Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

  2014cited by this paper
• The enhanced oral response to the 5-HT2 agonist Ro 60-0175 in parkinsonian rats involves the entopeduncular nucleus: electrophysiological correlates

  2013cited by this paper
• Adaptive Deep Brain Stimulation In Advanced Parkinson Disease

  2013cited by this paper
• Neurostimulation for Parkinson's disease with early motor complications.

  2013cited by this paper
• Timing of Deep Brain Stimulation in Parkinson Disease: A Need for Reappraisal?

  2013cited by this paper
• Phosphodiesterases: Regulators of cyclic nucleotide signals and novel molecular target for movement disorders.

  2013cited by this paper
• Early application of deep brain stimulation: clinical and ethical aspects.

  2013cited by this paper
• Role of 5-HT2C receptors in the enhancement of c-Fos expression induced by a 5-HT2B/2C inverse agonist and 5-HT2 agonists in the rat basal ganglia

  2013cited by this paper
• Intraoperative dopamine release during globus pallidus internus stimulation in Parkinson's disease

  2013cited by this paper
• Introduction to Festschrift/special issue: normal and abnormal neuronal oscillations in sensorimotor pathways.

  2013cited by this paper
• L-DOPA modifies the antidepressant-like effects of reboxetine and fluoxetine in rats.

  2013cited by this paper
• The Role of Inflammatory and Oxidative Stress Mechanisms in the Pathogenesis of Parkinson’s Disease: Focus on Astrocytes

  2013cited by this paper
• Psychiatric considerations in deep brain stimulation for Parkinson's disease.

  2013cited by this paper
• Deep brain stimulation improves survival in severe Parkinson's disease

  2013cited by this paper
• The real catecholamine content of secretory vesicles in the CNS revealed by electrochemical cytometry

  2013cited by this paper
• Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-study.

  2013cited by this paper
• Development of the Mayo Investigational Neuromodulation Control System: toward a closed-loop electrochemical feedback system for deep brain stimulation.

  2013cited by this paper
• Long-term subthalamic nucleus stimulation improves sensorimotor integration and proprioception

  2013cited by this paper
• Treatment of Parkinson’s Disease: What’s in the Non-dopaminergic Pipeline?

  2013cited by this paper
• Effect and safety of duodenal levodopa infusion in advanced Parkinson’s disease: a retrospective multicenter outcome assessment in patient routine care

  2013cited by this paper
• High-frequency stimulation of the substantia nigra induces serotonin-dependent depression-like behavior in animal models.

  2013cited by this paper
• A non-cholinergic neuronal loss in the pedunculopontine nucleus of toxin-evoked parkinsonian rats.

  2013cited by this paper
• Long‐term outcomes of surgical therapies for Parkinson's disease

  2012cited by this paper
• Effects of noradrenaline and serotonin depletions on the neuronal activity of globus pallidus and substantia nigra pars reticulata in experimental parkinsonism.

  2012cited by this paper
• Early gene mapping after deep brain stimulation in a rat model of tardive dyskinesia: comparison with transient local inactivation.

  2012cited by this paper
• Frequency selectivity and dopamine-dependence of plasticity at glutamatergic synapses in the subthalamic nucleus.

  2012cited by this paper
• Contribution of Serotonergic Transmission to the Motor and Cognitive Effects of High-Frequency Stimulation of the Subthalamic Nucleus or Levodopa in Parkinson’s Disease

  2012cited by this paper
• Stereotactic microdialysis of the basal ganglia in Parkinson's disease.

  2012cited by this paper
• Personality traits in patients with Parkinson’s disease: assessment and clinical implications

  2012cited by this paper
• GPi and STN deep brain stimulation can suppress dyskinesia in Parkinson's disease.

  2012cited by this paper
• Relevance of animal models to human tardive dyskinesia

  2012cited by this paper
• Deep brain stimulation of the accumbens increases dopamine, serotonin, and noradrenaline in the prefrontal cortex

  2012cited by this paper
• Reduced GABA Content in the Motor Thalamus during Effective Deep Brain Stimulation of the Subthalamic Nucleus

  2011influential reference
• Milestones in research on the pathophysiology of Parkinson's disease

  2011cited by this paper
• Nitric oxide modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders.

  2011cited by this paper
• Differential regulation of motor control and response to dopaminergic drugs by D1R and D2R neurons in distinct dorsal striatum subregions

  2011cited by this paper
• Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease.

  2011cited by this paper
• The clinical efficacy of -DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus

  2011influential reference
• Effective Subthalamic Nucleus Deep Brain Stimulation Sites May Differ for Tremor, Bradykinesia and Gait Disturbances in Parkinson’s Disease

  2011cited by this paper
• Reorganization of striatal inhibitory microcircuits leads to pathological synchrony in the Basal Ganglia.

  2011cited by this paper
• Activation of subthalamic neurons by contralateral subthalamic deep brain stimulation in Parkinson disease.

  2011cited by this paper
• Subthalamic Nucleus Stimulation Increases Brain Derived Neurotrophic Factor in the Nigrostriatal System and Primary Motor Cortex

  2011cited by this paper
• Noradrenaline and Parkinson's Disease

  2011cited by this paper

• The relationship between inflammatory markers in cerebrospinal fluid in healthy controls and in patients with severe Essential Tremor before and after deep brain stimulation

  2025cites this paper
• γ neuromodulations: unraveling biomarkers for neurological and psychiatric disorders

  2025cites this paper
• Noninvasive deep brain stimulation using theta-burst transcranial magnetic-acoustic coupling to modulate cortical rhythms in Parkinsonian mice.

  2025cites this paper
• Research on Local Field Potential Signal Classification Algorithm Based on Transfer Learning

  2024cites this paper
• Deep brain stimulation for Tourette's syndrome.

  2024cites this paper
• State identification of Parkinson’s disease based on transfer learning

  2024cites this paper
• Suppression of beta oscillations by delayed feedback in a cortex-basal ganglia-thalamus-pedunculopontine nucleus neural loop model

  2023cites this paper
• Inhibition of beta oscillations by delayed feedback in a cortex-basal ganglia-thalamus-pedunculopontine nucleus neural loop model

  2023cites this paper
• Up-Regulation of miR-9-5p Inhibits Hypoxia-Ischemia Brain Damage Through the DDIT4-Mediated Autophagy Pathways in Neonatal Mice

  2023cites this paper
• Suppression effects of delayed feedback schemes on pathological oscillations in the pedunculopontine nucleus: basal ganglia neural mass model

  2023cites this paper
• New Targets and New Technologies in the Treatment of Parkinson’s Disease: A Narrative Review

  2022cites this paper
• Dopaminergic medication normalizes aberrant cognitive control circuit signalling in Parkinson's disease.

  2022cites this paper
• Correlation of response to subthalamic deep brain stimulation in Parkinson’s disease patients with striatal dopamine transporter density on 99mtc-TRODAT-1 SPECT

  2022cites this paper
• Deep brain stimulation in animal models of dystonia.

  2022cites this paper
• Neurotrophins as Therapeutic Agents for Parkinson’s Disease; New Chances From Focused Ultrasound?

  2022cites this paper
• Oscillation suppression effects of intermittent noisy deep brain stimulation induced by coordinated reset pattern based on a computational model

  2022cites this paper
• Closing the loop of DBS using the beta oscillations in cortex

  2021cites this paper
• Striatal Afferent BDNF Is Disrupted by Synucleinopathy and Partially Restored by STN DBS

  2021cites this paper
• Serotonergic control of the glutamatergic neurons of the subthalamic nucleus.

  2021cites this paper
• Intensity-Varied Closed-Loop Noise Stimulation for Oscillation Suppression in the Parkinsonian State

  2021cites this paper
• Effective suppression of beta oscillation in Parkinsonian state via a noisy direct delayed feedback control scheme*

  2021cites this paper
• Efectos de la cirugía de estimulación cerebral profunda, sobre el aprendizaje motor en la Enfermedad de Parkinson

  2020cites this paper
• Motivation and motivational aspects of Parkinson's disease

  2020cites this paper
• Computational Modelling of Deep Brain Stimulation for Parkinson's Disease: A Critical Review

  2020cites this paper
• LED-Based Optical Neural Implants

  2020cites this paper
• Subthalamic Stimulation Inhibits Bladder Contraction by Modulating the Local Field Potential and Catecholamine Level of the Medial Prefrontal Cortex

  2020cites this paper
• Deep brain stimulation in Parkinson’s disease patients and routine 6‐OHDA rodent models: Synergies and pitfalls

  2020cites this paper
• Noninvasive Ultrasound Deep Brain Stimulation for the Treatment of Parkinson's Disease Model Mouse

  2019cites this paper
• Mood Effects After Deep Brain Stimulation for Parkinson's Disease: An Update

  2019cites this paper
• Proteomic Analysis of the Cerebrospinal Fluid in Patients With Essential Tremor Before and After Deep Brain Stimulation Surgery: A Pilot Study

  2019cites this paper
• Delayed Feedback-Based Suppression of Pathological Oscillations in a Neural Mass Model

  2019cites this paper
• BDNF provides many routes toward STN DBS‐mediated disease modification

  2018cites this paper
• Mathematical Modeling for Description of Oscillation Suppression Induced by Deep Brain Stimulation

  2018cites this paper
• Subthalamic nucleus deep brain stimulation protects neurons by activating autophagy via PP2A inactivation in a rat model of Parkinson's disease

  2018cites this paper
• Mechanisms of action underlying the efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease: central role of disease severity

  2018cites this paper
• Neurobiology and neuropharmacology of monoaminergic systems.

  2017cites this paper
• EDITORIAL OF THE SPECIAL ISSUE : NEUROBIOLOGY AND NEUROPHARMACOLOGY OF MONOAMINERGIC SYSTEMS

  2017cites this paper
• Comparison of in vivo solid-phase microextraction (SPME) to Folch extraction of brain lipids in Rattus norvegicus using LC-MS

  2017cites this paper